PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA
May 1, 2020, 00:00
10.1016/j.jval.2020.04.226
https://www.valueinhealthjournal.com/article/S1098-3015(20)30414-9/fulltext
Title :
PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30414-9&doi=10.1016/j.jval.2020.04.226
First page :
Section Title :
Open access? :
No
Section Order :
10084